Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvaro H Ingles Garces

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cancer Treatment Reviews|June 18, 2023
Clinical trial designs for evaluating and exploiting cancer evolutionAlvaro H Ingles Garces, Nuria Porta, Trevor A Graham, et al.
Expert Opinion on Investigational Drugs|July 31, 2019
Building on the anti-PD1/PD-L1 backbone: combination immunotherapy for cancerAlvaro H Ingles Garces, Lewis Au, Robert Mason, et al.
European Journal of Cancer (Oxford, England : 1990)|October 14, 2018
A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trialsAlvaro H Ingles Garces, Joo Ern Ang, Malaka Ameratunga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2020
First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid TumorsRobert McLeod, Rajiv Kumar, Dionysis Papadatos-Pastos, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cancer Treatment Reviews|June 18, 2023
Clinical trial designs for evaluating and exploiting cancer evolutionAlvaro H Ingles Garces, Nuria Porta, Trevor A Graham, et al.
Expert Opinion on Investigational Drugs|July 31, 2019
Building on the anti-PD1/PD-L1 backbone: combination immunotherapy for cancerAlvaro H Ingles Garces, Lewis Au, Robert Mason, et al.
European Journal of Cancer (Oxford, England : 1990)|October 14, 2018
A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trialsAlvaro H Ingles Garces, Joo Ern Ang, Malaka Ameratunga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2020
First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid TumorsRobert McLeod, Rajiv Kumar, Dionysis Papadatos-Pastos, et al.
Pageof 1